Selected research
Market Structure
Global Anti-thrombotic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-thrombotic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anti-thrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-thrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-thrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-thrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-thrombotic Drugs include Yantai Dongcheng North Pharmaceutical Co., Ltd., Tianjin Biochemical Pharmaceutical Co., Ltd., Tianjin Hongri Pharmaceutical Co., Ltd., Sichuan Changzheng Pharmaceutical Co., Ltd., Shijiazhuang Heping Pharmaceutical Factory, Shenzhen Saibaoer Biopharmaceutical Co., Ltd., Shandong Xinshidai Pharmaceutical Co., Ltd., Shandong Lvyin Pharmaceutical Co., Ltd. and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-thrombotic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-thrombotic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-thrombotic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-thrombotic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-thrombotic Drugs Segment by Company
Yantai Dongcheng North Pharmaceutical Co., Ltd.
Tianjin Biochemical Pharmaceutical Co., Ltd.
Tianjin Hongri Pharmaceutical Co., Ltd.
Sichuan Changzheng Pharmaceutical Co., Ltd.
Shijiazhuang Heping Pharmaceutical Factory
Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
Shandong Xinshidai Pharmaceutical Co., Ltd.
Shandong Lvyin Pharmaceutical Co., Ltd.
Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
Henan Yonghe Pharmaceutical Co., Ltd.
Chengdu Yuandong Biopharmaceutical Co., Ltd.
Chengdu Tongde Pharmaceutical Co., Ltd.
Chengdu Baiyu Pharmaceutical Co., Ltd.
Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
Beijing Taide Pharmaceutical Co., Ltd.
Beijing Shuanglu Pharmaceutical Co., Ltd.
Beijing Chengji Pharmaceutical Co., Ltd.
Teva
Sanofi
Sandoz
Pfizer
Johnson & Johnson
GlaxoSmithKline
Daiichi Sankyo
Bristol Myers Squibb
Boehringer Ingelheim Pharmaceuticals
Bayer
Anti-thrombotic Drugs Segment by Type
Platelet Aggregation Inhibitors
Enzymes
Heparins
Other
Anti-thrombotic Drugs Segment by Application
Clinic
Hospital
Other
Anti-thrombotic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-thrombotic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-thrombotic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-thrombotic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-thrombotic Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-thrombotic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-thrombotic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anti-thrombotic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Anti-thrombotic Drugs Industry Trends
Table 2. Anti-thrombotic Drugs Industry Drivers
Table 3. Anti-thrombotic Drugs Industry Opportunities and Challenges
Table 4. Anti-thrombotic Drugs Industry Restraints
Table 5. Global Anti-thrombotic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Anti-thrombotic Drugs Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Anti-thrombotic Drugs Sales by Manufacturers (K Units) & (2021-2026)
Table 8. Global Anti-thrombotic Drugs Sales Market Share by Manufacturers
Table 9. Global Anti-thrombotic Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026)
Table 10. Global Anti-thrombotic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Anti-thrombotic Drugs Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Anti-thrombotic Drugs Manufacturers, Product Type & Application
Table 13. Global Anti-thrombotic Drugs Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Anti-thrombotic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Platelet Aggregation Inhibitors
Table 17. Major Manufacturers of Enzymes
Table 18. Major Manufacturers of Heparins
Table 19. Major Manufacturers of Other
Table 20. Global Anti-thrombotic Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units)
Table 21. Global Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 22. Global Anti-thrombotic Drugs Sales by Type (2027-2032) & (K Units)
Table 23. Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Table 24. Global Anti-thrombotic Drugs Sales Market Share by Type (2027-2032)
Table 25. Global Anti-thrombotic Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units)
Table 26. Global Anti-thrombotic Drugs Revenue by Type (2021-2026) & (K Units)
Table 27. Global Anti-thrombotic Drugs Revenue by Type (2027-2032) & (K Units)
Table 28. Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2026)
Table 29. Global Anti-thrombotic Drugs Revenue Market Share by Type (2027-2032)
Table 30. Major Manufacturers of Clinic
Table 31. Major Manufacturers of Hospital
Table 32. Major Manufacturers of Other
Table 33. Global Anti-thrombotic Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units)
Table 34. Global Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 35. Global Anti-thrombotic Drugs Sales by Application (2027-2032) & (K Units)
Table 36. Global Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Table 37. Global Anti-thrombotic Drugs Sales Market Share by Application (2027-2032)
Table 38. Global Anti-thrombotic Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units)
Table 39. Global Anti-thrombotic Drugs Revenue by Application (2021-2026) & (K Units)
Table 40. Global Anti-thrombotic Drugs Revenue by Application (2027-2032) & (K Units)
Table 41. Global Anti-thrombotic Drugs Revenue Market Share by Application (2021-2026)
Table 42. Global Anti-thrombotic Drugs Revenue Market Share by Application (2027-2032)
Table 43. Global Anti-thrombotic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units)
Table 44. Global Anti-thrombotic Drugs Sales by Region (2021-2026) & (K Units)
Table 45. Global Anti-thrombotic Drugs Sales Market Share by Region (2021-2026)
Table 46. Global Anti-thrombotic Drugs Sales Forecasted by Region (2027-2032) & (K Units)
Table 47. Global Anti-thrombotic Drugs Sales Forecasted Market Share by Region (2027-2032)
Table 48. North America Anti-thrombotic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 49. North America Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 50. North America Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 51. Europe Anti-thrombotic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 52. Europe Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 53. Europe Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 54. Asia Pacific Anti-thrombotic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 55. Asia Pacific Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 56. Asia Pacific Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 57. South America, Middle East and Africa Anti-thrombotic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 58. South America, Middle East and Africa Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 59. South America, Middle East and Africa Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 60. Global Anti-thrombotic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 61. Global Anti-thrombotic Drugs Revenue by Region (2021-2026) & (US$ Million)
Table 62. Global Anti-thrombotic Drugs Revenue by Region (2027-2032) & (US$ Million)
Table 63. Global Anti-thrombotic Drugs Revenue Market Share by Region (2021-2026)
Table 64. Global Anti-thrombotic Drugs Revenue Market Share by Region (2027-2032)
Table 65. Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
Table 66. Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview
Table 67. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 69. Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Development
Table 70. Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
Table 71. Tianjin Biochemical Pharmaceutical Co., Ltd. Business Overview
Table 72. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 74. Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Development
Table 75. Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
Table 76. Tianjin Hongri Pharmaceutical Co., Ltd. Business Overview
Table 77. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 79. Tianjin Hongri Pharmaceutical Co., Ltd. Recent Development
Table 80. Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
Table 81. Sichuan Changzheng Pharmaceutical Co., Ltd. Business Overview
Table 82. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 84. Sichuan Changzheng Pharmaceutical Co., Ltd. Recent Development
Table 85. Shijiazhuang Heping Pharmaceutical Factory Company Information
Table 86. Shijiazhuang Heping Pharmaceutical Factory Business Overview
Table 87. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolio
Table 89. Shijiazhuang Heping Pharmaceutical Factory Recent Development
Table 90. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
Table 91. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Business Overview
Table 92. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 94. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Recent Development
Table 95. Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
Table 96. Shandong Xinshidai Pharmaceutical Co., Ltd. Business Overview
Table 97. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 99. Shandong Xinshidai Pharmaceutical Co., Ltd. Recent Development
Table 100. Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
Table 101. Shandong Lvyin Pharmaceutical Co., Ltd. Business Overview
Table 102. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 104. Shandong Lvyin Pharmaceutical Co., Ltd. Recent Development
Table 105. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
Table 106. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Business Overview
Table 107. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 109. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Recent Development
Table 110. Henan Yonghe Pharmaceutical Co., Ltd. Company Information
Table 111. Henan Yonghe Pharmaceutical Co., Ltd. Business Overview
Table 112. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 114. Henan Yonghe Pharmaceutical Co., Ltd. Recent Development
Table 115. Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
Table 116. Chengdu Yuandong Biopharmaceutical Co., Ltd. Business Overview
Table 117. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 119. Chengdu Yuandong Biopharmaceutical Co., Ltd. Recent Development
Table 120. Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
Table 121. Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview
Table 122. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 124. Chengdu Tongde Pharmaceutical Co., Ltd. Recent Development
Table 125. Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
Table 126. Chengdu Baiyu Pharmaceutical Co., Ltd. Business Overview
Table 127. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 129. Chengdu Baiyu Pharmaceutical Co., Ltd. Recent Development
Table 130. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
Table 131. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Business Overview
Table 132. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 134. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Recent Development
Table 135. Beijing Taide Pharmaceutical Co., Ltd. Company Information
Table 136. Beijing Taide Pharmaceutical Co., Ltd. Business Overview
Table 137. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 139. Beijing Taide Pharmaceutical Co., Ltd. Recent Development
Table 140. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
Table 141. Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
Table 142. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 144. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Development
Table 145. Beijing Chengji Pharmaceutical Co., Ltd. Company Information
Table 146. Beijing Chengji Pharmaceutical Co., Ltd. Business Overview
Table 147. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 149. Beijing Chengji Pharmaceutical Co., Ltd. Recent Development
Table 150. Teva Company Information
Table 151. Teva Business Overview
Table 152. Teva Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. Teva Anti-thrombotic Drugs Product Portfolio
Table 154. Teva Recent Development
Table 155. Sanofi Company Information
Table 156. Sanofi Business Overview
Table 157. Sanofi Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 158. Sanofi Anti-thrombotic Drugs Product Portfolio
Table 159. Sanofi Recent Development
Table 160. Sandoz Company Information
Table 161. Sandoz Business Overview
Table 162. Sandoz Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 163. Sandoz Anti-thrombotic Drugs Product Portfolio
Table 164. Sandoz Recent Development
Table 165. Pfizer Company Information
Table 166. Pfizer Business Overview
Table 167. Pfizer Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 168. Pfizer Anti-thrombotic Drugs Product Portfolio
Table 169. Pfizer Recent Development
Table 170. Johnson & Johnson Company Information
Table 171. Johnson & Johnson Business Overview
Table 172. Johnson & Johnson Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 173. Johnson & Johnson Anti-thrombotic Drugs Product Portfolio
Table 174. Johnson & Johnson Recent Development
Table 175. GlaxoSmithKline Company Information
Table 176. GlaxoSmithKline Business Overview
Table 177. GlaxoSmithKline Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 178. GlaxoSmithKline Anti-thrombotic Drugs Product Portfolio
Table 179. GlaxoSmithKline Recent Development
Table 180. Daiichi Sankyo Company Information
Table 181. Daiichi Sankyo Business Overview
Table 182. Daiichi Sankyo Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 183. Daiichi Sankyo Anti-thrombotic Drugs Product Portfolio
Table 184. Daiichi Sankyo Recent Development
Table 185. Bristol Myers Squibb Company Information
Table 186. Bristol Myers Squibb Business Overview
Table 187. Bristol Myers Squibb Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 188. Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolio
Table 189. Bristol Myers Squibb Recent Development
Table 190. Boehringer Ingelheim Pharmaceuticals Company Information
Table 191. Boehringer Ingelheim Pharmaceuticals Business Overview
Table 192. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 193. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolio
Table 194. Boehringer Ingelheim Pharmaceuticals Recent Development
Table 195. Bayer Company Information
Table 196. Bayer Business Overview
Table 197. Bayer Anti-thrombotic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 198. Bayer Anti-thrombotic Drugs Product Portfolio
Table 199. Bayer Recent Development
Table 200. Key Raw Materials
Table 201. Raw Materials Key Suppliers
Table 202. Anti-thrombotic Drugs Distributors List
Table 203. Anti-thrombotic Drugs Customers List
Table 204. Research Programs/Design for This Report
Table 205. Authors List of This Report
Table 206. Secondary Sources
Table 207. Primary Sources
List of Figures
Figure 1. Anti-thrombotic Drugs Product Image
Figure 2. Global Anti-thrombotic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Anti-thrombotic Drugs Market Size (2021-2032) & (US$ Million)
Figure 4. Global Anti-thrombotic Drugs Sales (2021-2032) & (K Units)
Figure 5. Global Anti-thrombotic Drugs Average Price (US$/Unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Anti-thrombotic Drugs Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Platelet Aggregation Inhibitors Image
Figure 9. Enzymes Image
Figure 10. Heparins Image
Figure 11. Other Image
Figure 12. Global Anti-thrombotic Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 13. Global Anti-thrombotic Drugs Sales Market Share 2021 VS 2025 VS 2032
Figure 14. Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2032)
Figure 15. Global Anti-thrombotic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 16. Global Anti-thrombotic Drugs Revenue Market Share 2021 VS 2025 VS 2032
Figure 17. Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2032)
Figure 18. Clinic Image
Figure 19. Hospital Image
Figure 20. Other Image
Figure 21. Global Anti-thrombotic Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 22. Global Anti-thrombotic Drugs Sales Market Share 2021 VS 2025 VS 2032
Figure 23. Global Anti-thrombotic Drugs Sales Market Share by Application (2021-2032)
Figure 24. Global Anti-thrombotic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 25. Global Anti-thrombotic Drugs Revenue Market Share 2021 VS 2025 VS 2032
Figure 26. Global Anti-thrombotic Drugs Revenue Market Share by Application (2021-2032)
Figure 27. North America Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 28. North America Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 29. U.S. Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 30. Canada Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 31. Mexico Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 32. Europe Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 33. Europe Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 34. Germany Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 35. France Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 36. U.K. Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 37. Italy Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 38. Netherlands Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 39. Asia Pacific Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 40. Asia Pacific Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 41. China Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 42. Japan Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 43. South Korea Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 44. Southeast Asia Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 45. India Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 46. Australia Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 47. South America, Middle East and Africa Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 48. South America, Middle East and Africa Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 49. Brazil Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 50. South Africa Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 51. Saudi Arabia Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 52. Turkey Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 53. Argentina Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 54. UAE Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 55. Egypt Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 56. Chile Anti-thrombotic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 57. Global Anti-thrombotic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Global Anti-thrombotic Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 59. North America Anti-thrombotic Drugs Revenue (2021-2032) & (US$ Million)
Figure 60. North America Anti-thrombotic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 61. Europe Anti-thrombotic Drugs Revenue (2021-2032) & (US$ Million)
Figure 62. Europe Anti-thrombotic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 63. Asia-Pacific Anti-thrombotic Drugs Revenue (2021-2032) & (US$ Million)
Figure 64. Asia-Pacific Anti-thrombotic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 65. South America, Middle East and Africa Anti-thrombotic Drugs Revenue (2021-2032) & (US$ Million)
Figure 66. South America, Middle East and Africa Anti-thrombotic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 67. Anti-thrombotic Drugs Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Anti-thrombotic Drugs Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
Scope & coverage.
Types
- Platelet Aggregation Inhibitors
- Enzymes
- Heparins
- Other
Applications
- Clinic
- Hospital
- Other
Companies covered
- Yantai Dongcheng North Pharmaceutical Co., Ltd.
- Tianjin Biochemical Pharmaceutical Co., Ltd.
- Tianjin Hongri Pharmaceutical Co., Ltd.
- Sichuan Changzheng Pharmaceutical Co., Ltd.
- Shijiazhuang Heping Pharmaceutical Factory
- Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
- Shandong Xinshidai Pharmaceutical Co., Ltd.
- Shandong Lvyin Pharmaceutical Co., Ltd.
- Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
- Henan Yonghe Pharmaceutical Co., Ltd.
- Chengdu Yuandong Biopharmaceutical Co., Ltd.
- Chengdu Tongde Pharmaceutical Co., Ltd.
- Chengdu Baiyu Pharmaceutical Co., Ltd.
- Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
- Beijing Taide Pharmaceutical Co., Ltd.
- Beijing Shuanglu Pharmaceutical Co., Ltd.
- Beijing Chengji Pharmaceutical Co., Ltd.
- Teva
- Sanofi
- Sandoz
- Pfizer
- Johnson & Johnson
- GlaxoSmithKline
- Daiichi Sankyo
- Bristol Myers Squibb
- Boehringer Ingelheim Pharmaceuticals
- Bayer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anti-thrombotic Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anti-thrombotic Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anti-thrombotic Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anti-thrombotic Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anti-thrombotic Drugs Market Dynamics
- 2.1 Anti-thrombotic Drugs Industry Trends
- 2.2 Anti-thrombotic Drugs Industry Drivers
- 2.3 Anti-thrombotic Drugs Industry Opportunities and Challenges
- 2.4 Anti-thrombotic Drugs Industry Restraints
3 Anti-thrombotic Drugs Market by Manufacturers
- 3.1 Global Anti-thrombotic Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Anti-thrombotic Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Anti-thrombotic Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anti-thrombotic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-thrombotic Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anti-thrombotic Drugs Manufacturers, Product Type & Application
- 3.7 Global Anti-thrombotic Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-thrombotic Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-thrombotic Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-thrombotic Drugs Tier 1, Tier 2, and Tier 3
4 Anti-thrombotic Drugs Market by Type
- 4.1 Anti-thrombotic Drugs Type Introduction
- 4.1.1 Platelet Aggregation Inhibitors
- 4.1.2 Enzymes
- 4.1.3 Heparins
- 4.1.4 Other
- 4.2 Global Anti-thrombotic Drugs Sales by Type
- 4.2.1 Global Anti-thrombotic Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-thrombotic Drugs Sales by Type (2021-2032)
- 4.2.3 Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Anti-thrombotic Drugs Revenue by Type
- 4.3.1 Global Anti-thrombotic Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-thrombotic Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2032)
5 Anti-thrombotic Drugs Market by Application
- 5.1 Anti-thrombotic Drugs Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Other
- 5.2 Global Anti-thrombotic Drugs Sales by Application
- 5.2.1 Global Anti-thrombotic Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-thrombotic Drugs Sales by Application (2021-2032)
- 5.2.3 Global Anti-thrombotic Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Anti-thrombotic Drugs Revenue by Application
- 5.3.1 Global Anti-thrombotic Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-thrombotic Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Anti-thrombotic Drugs Revenue Market Share by Application (2021-2032)
6 Global Anti-thrombotic Drugs Sales by Region
- 6.1 Global Anti-thrombotic Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-thrombotic Drugs Sales by Region (2021-2032)
- 6.2.1 Global Anti-thrombotic Drugs Sales by Region (2021-2026)
- 6.2.2 Global Anti-thrombotic Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anti-thrombotic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anti-thrombotic Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anti-thrombotic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anti-thrombotic Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anti-thrombotic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anti-thrombotic Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anti-thrombotic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anti-thrombotic Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anti-thrombotic Drugs Revenue by Region
- 7.1 Global Anti-thrombotic Drugs Revenue by Region
- 7.1.1 Global Anti-thrombotic Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anti-thrombotic Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Anti-thrombotic Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Anti-thrombotic Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anti-thrombotic Drugs Revenue (2021-2032)
- 7.2.2 North America Anti-thrombotic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anti-thrombotic Drugs Revenue (2021-2032)
- 7.3.2 Europe Anti-thrombotic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anti-thrombotic Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anti-thrombotic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anti-thrombotic Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anti-thrombotic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yantai Dongcheng North Pharmaceutical Co., Ltd.
- 8.1.1 Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
- 8.1.2 Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview
- 8.1.3 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.1.5 Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments
- 8.2 Tianjin Biochemical Pharmaceutical Co., Ltd.
- 8.2.1 Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
- 8.2.2 Tianjin Biochemical Pharmaceutical Co., Ltd. Business Overview
- 8.2.3 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.2.5 Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Developments
- 8.3 Tianjin Hongri Pharmaceutical Co., Ltd.
- 8.3.1 Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
- 8.3.2 Tianjin Hongri Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.3.5 Tianjin Hongri Pharmaceutical Co., Ltd. Recent Developments
- 8.4 Sichuan Changzheng Pharmaceutical Co., Ltd.
- 8.4.1 Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
- 8.4.2 Sichuan Changzheng Pharmaceutical Co., Ltd. Business Overview
- 8.4.3 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.4.5 Sichuan Changzheng Pharmaceutical Co., Ltd. Recent Developments
- 8.5 Shijiazhuang Heping Pharmaceutical Factory
- 8.5.1 Shijiazhuang Heping Pharmaceutical Factory Company Information
- 8.5.2 Shijiazhuang Heping Pharmaceutical Factory Business Overview
- 8.5.3 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolio
- 8.5.5 Shijiazhuang Heping Pharmaceutical Factory Recent Developments
- 8.6 Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
- 8.6.1 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
- 8.6.2 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Business Overview
- 8.6.3 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.6.5 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Recent Developments
- 8.7 Shandong Xinshidai Pharmaceutical Co., Ltd.
- 8.7.1 Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
- 8.7.2 Shandong Xinshidai Pharmaceutical Co., Ltd. Business Overview
- 8.7.3 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.7.5 Shandong Xinshidai Pharmaceutical Co., Ltd. Recent Developments
- 8.8 Shandong Lvyin Pharmaceutical Co., Ltd.
- 8.8.1 Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
- 8.8.2 Shandong Lvyin Pharmaceutical Co., Ltd. Business Overview
- 8.8.3 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.8.5 Shandong Lvyin Pharmaceutical Co., Ltd. Recent Developments
- 8.9 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
- 8.9.1 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
- 8.9.2 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Business Overview
- 8.9.3 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.9.5 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Recent Developments
- 8.10 Henan Yonghe Pharmaceutical Co., Ltd.
- 8.10.1 Henan Yonghe Pharmaceutical Co., Ltd. Company Information
- 8.10.2 Henan Yonghe Pharmaceutical Co., Ltd. Business Overview
- 8.10.3 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.10.5 Henan Yonghe Pharmaceutical Co., Ltd. Recent Developments
- 8.11 Chengdu Yuandong Biopharmaceutical Co., Ltd.
- 8.11.1 Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
- 8.11.2 Chengdu Yuandong Biopharmaceutical Co., Ltd. Business Overview
- 8.11.3 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.11.5 Chengdu Yuandong Biopharmaceutical Co., Ltd. Recent Developments
- 8.12 Chengdu Tongde Pharmaceutical Co., Ltd.
- 8.12.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
- 8.12.2 Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview
- 8.12.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.12.5 Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments
- 8.13 Chengdu Baiyu Pharmaceutical Co., Ltd.
- 8.13.1 Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
- 8.13.2 Chengdu Baiyu Pharmaceutical Co., Ltd. Business Overview
- 8.13.3 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.13.5 Chengdu Baiyu Pharmaceutical Co., Ltd. Recent Developments
- 8.14 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
- 8.14.1 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
- 8.14.2 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Business Overview
- 8.14.3 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.14.5 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Recent Developments
- 8.15 Beijing Taide Pharmaceutical Co., Ltd.
- 8.15.1 Beijing Taide Pharmaceutical Co., Ltd. Company Information
- 8.15.2 Beijing Taide Pharmaceutical Co., Ltd. Business Overview
- 8.15.3 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.15.5 Beijing Taide Pharmaceutical Co., Ltd. Recent Developments
- 8.16 Beijing Shuanglu Pharmaceutical Co., Ltd.
- 8.16.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
- 8.16.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
- 8.16.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.16.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
- 8.17 Beijing Chengji Pharmaceutical Co., Ltd.
- 8.17.1 Beijing Chengji Pharmaceutical Co., Ltd. Company Information
- 8.17.2 Beijing Chengji Pharmaceutical Co., Ltd. Business Overview
- 8.17.3 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 8.17.5 Beijing Chengji Pharmaceutical Co., Ltd. Recent Developments
- 8.18 Teva
- 8.18.1 Teva Company Information
- 8.18.2 Teva Business Overview
- 8.18.3 Teva Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Teva Anti-thrombotic Drugs Product Portfolio
- 8.18.5 Teva Recent Developments
- 8.19 Sanofi
- 8.19.1 Sanofi Company Information
- 8.19.2 Sanofi Business Overview
- 8.19.3 Sanofi Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Sanofi Anti-thrombotic Drugs Product Portfolio
- 8.19.5 Sanofi Recent Developments
- 8.20 Sandoz
- 8.20.1 Sandoz Company Information
- 8.20.2 Sandoz Business Overview
- 8.20.3 Sandoz Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Sandoz Anti-thrombotic Drugs Product Portfolio
- 8.20.5 Sandoz Recent Developments
- 8.21 Pfizer
- 8.21.1 Pfizer Company Information
- 8.21.2 Pfizer Business Overview
- 8.21.3 Pfizer Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Pfizer Anti-thrombotic Drugs Product Portfolio
- 8.21.5 Pfizer Recent Developments
- 8.22 Johnson & Johnson
- 8.22.1 Johnson & Johnson Company Information
- 8.22.2 Johnson & Johnson Business Overview
- 8.22.3 Johnson & Johnson Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 Johnson & Johnson Anti-thrombotic Drugs Product Portfolio
- 8.22.5 Johnson & Johnson Recent Developments
- 8.23 GlaxoSmithKline
- 8.23.1 GlaxoSmithKline Company Information
- 8.23.2 GlaxoSmithKline Business Overview
- 8.23.3 GlaxoSmithKline Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 GlaxoSmithKline Anti-thrombotic Drugs Product Portfolio
- 8.23.5 GlaxoSmithKline Recent Developments
- 8.24 Daiichi Sankyo
- 8.24.1 Daiichi Sankyo Company Information
- 8.24.2 Daiichi Sankyo Business Overview
- 8.24.3 Daiichi Sankyo Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.24.4 Daiichi Sankyo Anti-thrombotic Drugs Product Portfolio
- 8.24.5 Daiichi Sankyo Recent Developments
- 8.25 Bristol Myers Squibb
- 8.25.1 Bristol Myers Squibb Company Information
- 8.25.2 Bristol Myers Squibb Business Overview
- 8.25.3 Bristol Myers Squibb Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.25.4 Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolio
- 8.25.5 Bristol Myers Squibb Recent Developments
- 8.26 Boehringer Ingelheim Pharmaceuticals
- 8.26.1 Boehringer Ingelheim Pharmaceuticals Company Information
- 8.26.2 Boehringer Ingelheim Pharmaceuticals Business Overview
- 8.26.3 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.26.4 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolio
- 8.26.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
- 8.27 Bayer
- 8.27.1 Bayer Company Information
- 8.27.2 Bayer Business Overview
- 8.27.3 Bayer Anti-thrombotic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.27.4 Bayer Anti-thrombotic Drugs Product Portfolio
- 8.27.5 Bayer Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-thrombotic Drugs Value Chain Analysis
- 9.1.1 Anti-thrombotic Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-thrombotic Drugs Production Mode & Process
- 9.2 Anti-thrombotic Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-thrombotic Drugs Distributors
- 9.2.3 Anti-thrombotic Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst